跳至主要内容
临床试验/NCT03902106
NCT03902106Unknown不适用

Physiological Response to Salbutamol and Exercise

University of Copenhagen1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年3月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Maximal oxygen consumption (VO2max)

研究概览

简要总结

The scope of the study is to investigate the physiological response to salbutamol and exercise. A particular focus is on the metabolic response and amine metabolism.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • VO2max of >55 ml/min/kg for men and >50 ml/min/kg for women
  • Body mass index (BMI) < 26

排除标准

  • Chronic use of beta2-agonist or allergy towards beta2-agonist
  • Serious adverse effects to beta2-agonist
  • Chronic disease deemed by the study responsible medical doctor to interfere with any part of the study
  • Chronic use of prescription medicine deemed by the study responsible medical doctor to interfere with any part of the study
  • Pregnancy (for women)

研究组 & 干预措施

beta2-agonist and exercise

Active Comparator

Subjects undergo exercise training with administration of salbutamol (800 microgram in 12 hours x 2)

干预措施: salbutamol (Drug)

beta2-agonist and exercise

Active Comparator

Subjects undergo exercise training with administration of salbutamol (800 microgram in 12 hours x 2)

干预措施: exercise (Other)

placebo and exercise

Sham Comparator

Subjects undergo exercise training with administration of sham placebo

干预措施: exercise (Other)

结局指标

主要结局

Maximal oxygen consumption (VO2max)

时间窗: Baseline, 2 weeks, 4 weeks and 6 weeks

Change in VO2max (measured during bike ergometer cycling to exhaustion)

Body composition

时间窗: Baseline, 2 weeks, 4 weeks and 6 weeks

Change in body composition (measured by dual energy x ray absorptiometry)

次要结局

  • Salbutamol urine concentration(Before (baseline) as well as 0-1 hours, 1-2 hours, 2-4 hours, 4-8 hours, and 8-16 hours after administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Morten Hostrup, PhD

Associate Professor

University of Copenhagen

研究点 (1)

Loading locations...

相似试验